Histone deacetylase inhibitors in oral squamous cell carcinoma treatment

Jason TasoulasNational and Kapodistrian University of Athens, Medical School, First Department of Pathology, Athens, Greece

Constantinos GiaginisNational and Kapodistrian University of Athens, Medical School, First Department of Pathology, Athens, Greece;University of the Aegean, School of Environment, Department of Food Science and Nutrition, 2 Mitropoliti Ioakeim Street, Myrina, Lemnos 81400, Greece+30 22540 83117; +30 22540 83109; [email protected]

, MSc PhD (Associate) (Assistant Professor of Human Physiology) (Associate) (Assistant Professor of Human Physiology) ,

Efstratios PatsourisNational and Kapodistrian University of Athens, Medical School, First Department of Pathology, Athens, Greece

Evangelos ManolisNational and Kapodistrian University of Athens, Medical School, First Department of Pathology, Athens, Greece

Stamatios TheocharisNational and Kapodistrian University of Athens, Medical School, First Department of Pathology, Athens, Greece

Histone deacetylase inhibitors in oral squamous cell carcinoma treatment

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Histone deacetylase inhibitors in oral squamous cell carcinoma treatment

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date